Filing Details
- Accession Number:
- 0001225208-25-001195
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-04 19:00:36
- Reporting Period:
- 2025-02-03
- Filing Date:
- 2025-02-04
- Accepted Time:
- 2025-02-04 19:00:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1678249 | C Arthur Butcher | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp& Grp Pres, Medsurg & Apac | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-03 | 6,952 | $27.09 | 12,454 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-03 | 6,176 | $24.55 | 18,630 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-03 | 3,176 | $22.71 | 21,806 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-03 | 1,009 | $17.26 | 22,815 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-03 | 8,508 | $101.45 | 14,307 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-03 | 8,805 | $102.14 | 5,502 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-03 | 6,952 | $0.00 | 6,952 | $27.09 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-03 | 1,009 | $0.00 | 1,009 | $17.26 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-03 | 6,176 | $0.00 | 6,176 | $24.55 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-03 | 3,176 | $0.00 | 3,176 | $22.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,856 | 2028-02-15 | No | 4 | M | Direct | |
| 3,027 | 2026-02-22 | No | 4 | M | Direct | |
| 18,527 | 2027-02-28 | No | 4 | M | Direct | |
| 9,530 | 2026-06-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,364 | Indirect | By 401(k) |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.895 to $101.86, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.93 to $102.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
- Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.
Billionaire Hedge Funds
